A San Diego startup is planning to use its latest round of funds to develop a treatment for cancers that have become treatment resistant. Aragon Pharmaceuticals has a drug for prostate cancer in early stage trials and is planning early stage studies targeting the estrogen receptor in women with breast cancer. The company raised $42 million in a Series C financing led by a new investor, the Topspin Fund.
Four independent pharmacies are suing the Centers for Medicare and Medicaid Services over their loss of customers to the preferred pharmacy networks created by the Part D drug plan. The group says that the law creating the drug benefit does not include language about preferred pharmacies’ or differential cost-sharing.
A lawyer who helped to write a report on the security of electronic health records says that there are huge holes in the system that are already causing big lawsuits. James Pyles says that Pyles said a class-action lawsuit almost always follows a privacy breach and cases usually settle for about $20 million. (free subscription required) Download a copy of the report–The Financial Impact of Breached Protected Health Information–here for free.
German researchers say their new data mining tool can read free text in radiology reports and make these reports easier to use and share. Averbis GmbH reports that the tool can identify and sort information based on size, time and date, image references and abbreviations.
The New England Journal of Medicine says the term “patient-centered care” shifts the balance of the doctor-patient relationship too far in one direction. Dr. Charles L. Bardes thinks that this term is a poor substitute for the “doctor-centered care” model that had been the standard. A metaphor that emphasizes collaboration and compromise would be the most accurate description.
By Veronica Combs
I am the editor in chief at MedCityNews.com. I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.More posts by Author













